文献速递心脏核医学

心脏磁共振成像与氟脱氧葡萄糖正电子发射断层显像评估心脏结节病的比较:荟萃分析与系统综述

Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of cardiac sarcoidosis: Meta-analysis and systematic review.
PubMed 文献 · J Nucl Cardiol · 2022-11-28

该荟萃分析与系统综述比较了FDG-PET与CMR诊断心脏结节病的诊断参数,共纳入4项研究、237例患者,以不良结局为参考标准。CMR预测不良事件的汇总灵敏度为0.94(95%CI 0.79-0.98),特异度为0.49(95%CI 0.40-0.59);FDG-PET的汇总灵敏度为0.51(95%CI 0.26-0.75),特异度为0.60(95%CI 0.35-0.81)。结论认为CMR较FDG-PET更敏感但特异度更低,解读结果时需考虑研究人群和阳性试验定义。

要点

  • 共纳入4项研究、237例患者,其中男性占60.3%,年龄范围为50-53岁,共45例事件。
  • CMR预测不良事件的汇总灵敏度为0.94(95%CI 0.79-0.98),特异度为0.49(95%CI 0.40-0.59)。
  • FDG-PET预测不良事件的汇总灵敏度为0.51(95%CI 0.26-0.75),特异度为0.60(95%CI 0.35-0.81)。

核心结论

  • CMR预测不良事件较FDG-PET更敏感但特异度更低;解读结果时需考虑研究人群和阳性试验定义。

研究设计与样本

  • 系统检索PubMed、EMBASE和Scopus数据库(从建库至2021年9月30日),检索词为「心脏结节病」且「心脏磁共振成像」且「正电子发射断层显像」。
  • 纳入4项提供不良结局且所有患者均接受FDG-PET和CMR的研究,共237例患者,男性占60.3%,年龄范围为50-53岁,共45例事件。
  • 以不良结局作为评估FDG-PET和CMR的参考标准,提取患者特征、FDG-PET和CMR结果及不良结局进行荟萃分析。

主要发现

  • CMR预测不良事件的汇总灵敏度为0.94(95%CI 0.79-0.98),汇总特异度为0.49(95%CI 0.40-0.59)。
  • FDG-PET预测不良事件的汇总灵敏度为0.51(95%CI 0.26-0.75),汇总特异度为0.60(95%CI 0.35-0.81)。

关键数值与推荐

  • CMR预测不良事件的汇总灵敏度为0.94(95%CI 0.79-0.98),特异度为0.49(95%CI 0.40-0.59)。
  • FDG-PET预测不良事件的汇总灵敏度为0.51(95%CI 0.26-0.75),特异度为0.60(95%CI 0.35-0.81)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文指出解读结果时需考虑研究人群和阳性试验定义。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: Fluorine-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) and cardiac magnetic resonance (CMR) are frequently used advanced cardiac imaging to diagnose cardiac sarcoidosis (CS). We conducted a meta-analysis and systematic review to compare diagnostic parameters of FDG-PET and CMR in the diagnosis of cardiac sarcoidosis (CS). METHODS: We searched PubMed, EMBASE, and Scopus databases from their inception to 9/30/2021 with search terms "cardiac sarcoidosis" AND "cardiac magnetic resonance imaging" AND "positronemission tomography". We extracted patient characteristics, results of the FDG-PET and CMR, and adverse outcomes from the included studies. Adverse outcomes served as a reference standard for the evaluation of FDG-PET and CMR. RESULTS: We included 4 studies in the meta-analysis which provided adverse outcomes and all patients underwent FDG-PET and CMR. There were 237 patients, 60.3% male, and ages ranged from 50-53 years. There were 45 events in 237 patients from four studies included in the meta-analyses. The pooled sensitivity (95% confidence interval-CI) and specificity (CI) of CMR in predicting an adverse event were 0.94 (0.79-0.98) and 0.49 (0.40-0.59), respectively. The pooled sensitivity (CI) and specificity (CI) of FDG-PET in predicting an adverse event were 0.51 (0.26-0.75) and 0.60 (0.35-0.81), respectively. CONCLUSION: CMR was more sensitive but less specific than FDG-PET in predicting adverse events; however, the study population and definition of a positive test need to be considered while interpreting the results.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Adhaduk M, Paudel B, Khalid MU, et al. Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of cardiac sarcoidosis: Meta-analysis and systematic review. J Nucl Cardiol. 2022. PMID: 36443587. doi:10.1007/s12350-022-03129-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。